Drug Maker, Execs Sued Over Alleged Involvement In Stock Pump-And-Dump Scheme
TACOMA, Wash. — A biotechnology company and two of its senior executives violated federal securities laws by misrepresenting to investors that its HIV-treatment drug could be used as a treatment for...To view the full article, register now.
Already a subscriber? Click here to view full article